Company intelligence / Profile preview

Blackbird Labs

Baltimore, Maryland, United Statesblackbirdlab.org ↗

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Blackbird Labs is a nonprofit life sciences accelerator focused on translating academic research into commercial biotech ventures. It has launched with a $100 million grant, established collaborations with leading Baltimore institutions, and is advancing programs in gut-targeted therapeutics for inflammatory bowel diseases, small molecule therapies for schizophrenia, and a precision gene therapy platform. The company also supports digital health initiatives to improve clinical trial enrollment[1][2][5][6].

Therapeutic areas: GastroenterologyPsychiatry
Modalities: Small moleculeGene therapyDigital platform (for clinical trial navigation)
Industry: Investors

Partnerships

Johns Hopkins UniversityUniversity of Maryland BaltimoreLieber Institute for Brain Development

Beyond the preview

Go deeper on Blackbird Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blackbird Labs.

Explore the full profile